VIATRIS INC. Restructuring Reserve, Period Increase (Decrease)
VIATRIS INC. (VTRS) reported Restructuring Reserve, Period Increase (Decrease) of -$8.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodIncreaseDecrease · last filed 2022-02-28
- VIATRIS INC. restructuring reserve, period increase (decrease) for fiscal 2019 was -$8.10M.
| Period end | Restructuring Reserve, Period Increase (Decrease) 12 month | Restructuring Reserve, Period Increase (Decrease) 12 month as first filed |
|---|---|---|
| 2019-12-31 | -$8.10M 10-K · filed 2022-02-28 | $8.10M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |